Cargando…

Risk subtyping and prognostic assessment of prostate cancer based on consensus genes

Prostate cancer (PCa) is the most frequent malignancy in male urogenital system around worldwide. We performed molecular subtyping and prognostic assessment based on consensus genes in patients with PCa. Five cohorts containing 1,046 PCa patients with RNA expression profiles and recorded clinical fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Jialin, Guan, Yu, Wang, Bijun, Chen, Lei, Chen, Junyi, Zhang, Meng, Liang, Chaozhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924191/ https://www.ncbi.nlm.nih.gov/pubmed/35293897 http://dx.doi.org/10.1038/s42003-022-03164-8

Ejemplares similares

Establishment of a five‐enzalutamide‐resistance‐related‐gene‐based classifier for recurrence‐free survival predicting of prostate cancer
por: Chen, Jing, et al.
Publicado: (2022)

Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients
por: Che, Hong, et al.
Publicado: (2019)

Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel‐like factors in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2020)

A New Nomogram Allowing Physicians to Predict Patients at High Risk of Fever Occurring After Prostate Biopsy
por: Xia, Haoran, et al.
Publicado: (2020)

Integrated multi‐omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer
por: Meng, Jialin, et al.
Publicado: (2021)

The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2019)

Single‐cell multi‐omics analysis presents the landscape of peripheral blood T‐cell subsets in human chronic prostatitis/chronic pelvic pain syndrome
por: Zhang, Meng, et al.
Publicado: (2020)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)

Establishment of an age‐ and tumor microenvironment‐related gene signature for survival prediction in prostate cancer
por: Chen, Lei, et al.
Publicado: (2022)

The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies
por: Chen, Lei, et al.
Publicado: (2022)

In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
por: Zhang, Meng, et al.
Publicado: (2023)

Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients
por: Bian, Zichen, et al.
Publicado: (2021)

Immune response drives outcomes in prostate cancer: implications for immunotherapy
por: Meng, Jialin, et al.
Publicado: (2020)

Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review
por: Meng, Jialin, et al.
Publicado: (2018)

Development and external validation of a nomogram for predicting renal function based on preoperative data from in-hospital patients with simple renal cysts
por: Chen, Yiding, et al.
Publicado: (2022)

Clinical value of prostate-specific antigen combined with tumor abnormal protein (TAP) in the diagnosis of prostate puncture
por: Guan, Yu, et al.
Publicado: (2020)

Genetic Polymorphisms of IFNG, IFNGR1, and Androgen Receptor and Chronic Prostatitis/Chronic Pelvic Pain Syndrome in a Chinese Han Population
por: Chen, Lei, et al.
Publicado: (2021)

Nomogram for predicting the overall survival of patients with early‐onset prostate cancer: A population‐based retrospective study
por: Hu, Yongtao, et al.
Publicado: (2022)

Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
por: Ge, Shengdong, et al.
Publicado: (2021)

The Role of Polymorphisms in Genes of PI3K/Akt Signaling Pathway on Prostate
por: Xu, Wei, et al.
Publicado: (2019)

EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort
por: Ge, Qintao, et al.
Publicado: (2022)

Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer
por: Xu, Lingfan, et al.
Publicado: (2019)

hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis
por: Xu, Hanjiang, et al.
Publicado: (2022)

Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression
por: Zhang, Meng, et al.
Publicado: (2021)

Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
por: Liu, Yi, et al.
Publicado: (2018)

Establishment of Novel Prostate Cancer Risk Subtypes and A Twelve-Gene Prognostic Model
por: Zhang, Enchong, et al.
Publicado: (2021)

Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model
por: Zhang, Yanlong, et al.
Publicado: (2020)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
por: Bian, Zichen, et al.
Publicado: (2022)

Characterization of Immune-Based Molecular Subtypes and Prognostic Model in Prostate Adenocarcinoma
por: Guo, Li, et al.
Publicado: (2022)

Higher Intake of Fat, Vitamin E-(β+γ), Magnesium, Sodium, and Copper Increases the Susceptibility to Prostatitis-like Symptoms: Evidence from a Chinese Adult Cohort
por: Zhang, Meng, et al.
Publicado: (2022)

Development of Mobile Application for Dynamically Monitoring the Risk of Prostate Cancer and Clinicopathology
por: Wang, Hui, et al.
Publicado: (2020)

TP73 G4C14-A4T14 polymorphism and cancer susceptibility: evidence from 36 case–control studies
por: Meng, Jialin, et al.
Publicado: (2018)

Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
por: Wang, Hongzhi, et al.
Publicado: (2021)

Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
por: Zhang, Meng, et al.
Publicado: (2022)

Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
por: Kang, Zhen, et al.
Publicado: (2023)

Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
por: Lu, Xiaofan, et al.
Publicado: (2021)

Association of Cytokine Gene Polymorphisms with Prostate Cancer Risk from a Study in Central China
por: Xu, Shun, et al.
Publicado: (2022)

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer
por: Bian, Zichen, et al.
Publicado: (2020)

Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair‐based signature
por: Lu, Xiaofan, et al.
Publicado: (2021)

Breast Cancer Consensus Subtypes: A system for subtyping breast cancer tumors based on gene expression
por: Horr, Christina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mb3rkaotdccp0njgc9d84glp4m